Legal Representation
Attorney
Yong Chen
USPTO Deadlines
Next Deadline
1142 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230307)
Due Date
March 07, 2029
Grace Period Ends
September 07, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 7, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 7, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 20, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 20, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 30, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 15, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 3, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 3, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 3, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 20, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 23, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 23, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 23, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 16, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 9, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 28, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cancer and tumors; biological preparations for the treatment of cancer and tumors; Cytostatics for medical purposes; medical diagnostic reagents; anticancer preparations; Biological preparations for the treatment of cancer; Tumor suppressing agents; anti-sarcoma preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of cancer
Additional Information
Design Mark
The mark consists of three Chinese characters that transliterate to "Yuan Rui Da".
Other
The non-Latin characters in the mark transliterate to "Yuan Rui Da" and this means "Source, Lucky, Eminent" in English.
Classification
International Classes
005